Search

everythinglearnresearchcommunity

for

Search:↓

4-O-Methylhonokiol from Magnolia shows promise for hair growth, cancer, diabetes, and more, but needs better absorption.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Platelets play a key role in the immune system and their lifespan and aging are important for developing new treatments.

Biologics for severe asthma have known side effects, but some new risks need more study.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

PCOS diagnosis and management have improved with new guidelines for personalized care.

PRP therapy may help with ovarian issues and fertility, but more research is needed.

New drug uses show promise but need more research.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Minoxidil ingestion can raise liver enzyme levels.

Certain cannabinoids may help increase hair growth and could be useful for treating hair loss.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The enzymes Tet1, Tet2, and Tet3 are important for the development of hair follicles and determining hair shape by controlling hair keratin genes.

The model can effectively test gene functions and drug responses in human skin.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Using a stimulating cream shampoo before applying Minoxidil helps it penetrate hair follicles better, enhancing its hair growth-promoting effect.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.